Odontogenic Descending Necrotizing Mediastinitis in a Patient with Severe Allergy to Beta-Lactam Antibiotics: A Case Report and Literature Review
PDF
Cite
Share
Request
CASE REPORT
P: 12-12
January 2013

Odontogenic Descending Necrotizing Mediastinitis in a Patient with Severe Allergy to Beta-Lactam Antibiotics: A Case Report and Literature Review

Mediterr J Infect Microb Antimicrob 2013;2(2):12-12
1. Kartal Dr. Lütfi Kırdar Eğitim ve Araştırma Hastanesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği, İstanbul, Türkiye
2. İstanbul Medipol Üniversitesi Tıp Fakültesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı, İstanbul, Türkiye
3. Kartal Dr. Lütfi Kırdar Eğitim ve Araştırma Hastanesi, Göğüs Cerrahisi Kliniği, İstanbul, Türkiye
No information available.
No information available
PDF
Cite
Share
Request

Summary

Descending necrotizing mediastinitis (DNM) is caused by aerobic and anaerobic bacteria as a rare but severe complication of oropharyngeal abscesses developing secondary to odontogenic infections. Patients with hypersensitivity reaction to beta-lactam antibiotics pose challenges in the treatment. To our knowledge, only two cases of postoperative mediastinitis treated with tigecycline have been reported in the English medical literature to date. In this paper, we present a case of descending mediastinitis developing one week after dental extraction. The patient was given tigecycline treatment with the diagnosis of complicated deep neck infection, which progressed to descending mediastinitis because of severe allergic reaction to beta-lactam group antimicrobials. He successfully recovered after early surgical drainage and debridement together with four weeks of tigecycline therapy. Tigecycline may be an alternative option for treatment of odontogenic infections and descending mediastinitis in beta-lactamallergic patients. It may be used effectively and successfully with concurrent standard early surgical intervention in selected patients, especially in those with severe hypersensitivity reaction.

Keywords:
Descending necrotizing mediastinitis, odontogenic, beta-lactam allergy, hypersensitivity reaction, tigecycline

Introduction

Mediastinitis occurs due to perforation of the esophagus or after cardiac surgery, head and neck infections, and dissemination from another focus of infection[1]. Suppurative odontogenic infections may cause life-threatening complications by extending along deep fascial layers of the head and neck[2]. Descending necrotizing mediastinitis (DNM) occurs as a rare but severe complication of oropharyngeal abscesses developing secondary to odontogenic infections[3, 4]. The relevant mortality has been reported to be 40-50% because of rapid dissemination of the infection[5, 6]. Early diagnosis, control of the infective focus and effective long-lasting antibiotic treatment are lifesaving principles in the management of mediastinitis. In this paper, we present a case of descending mediastinitis developing one week after dental extraction.

Discussion

In the case series of Boscolo-Rizzo and his coworkers including 167 patients with deep neck infection, only six cases had DNM[10]. In another case series of 10 patients, only three cases developed mediastinitis secondary to odontogenic abscess after dental extraction. Eight of these 10 patients were treated successfully where as two cases (1 patient over 75 years old and the other diabetic) died because of septic shock and multiorgan failure[11]. In a report of 105 cases (aged 18-93 years) with deep cervical infection, older age (> 65 years), accompanying systemic disease, and in appropriate empirical antimicrobial therapy were statistically significant parameters for lifethreatening complications[12].

Pathogens causing mediastinitis include aerobic and anaerobic Gram-positive cocci and bacilli, and Candida albicans[1]. However, prior antibiotic use, just as in our patient, decreases the possibility of microbial isolation from the culture. CT is important in the early diagnosis and surgical management of DNM[13].

The primary treatment of DNM is surgical eradication of the pharyngeal or odontogenic infectious focus and concurrent drainage of the cervical and/or mediastinal collection. Relevant mortality is considerably high despite appropriate therapy[14]. Hsu and his colleagues reported in their DNM series of 29 patients that treatment with early, aggressive transcervical drainage and debridement was equally as successful as combined cervical and thoracic drainage[15]. The decision regarding type of surgical approach is made according to the extent of the infection and the experience of the surgeon[16, 17]. Cervical and mediastinal drainage was performed by transcervical approach in our patient.

Ampicillin-sulbactam, amoxicillin-clavulanate, penicillin G and metronidazole combination, cefoxitin, or cefotetan is recommended in the treatment of odontogenic infections in immunocompetent patients. For beta-lactam-allergic patients, clindamycin or moxifloxacin may be recommended. Broad-spectrum beta-lactam and beta-lactamase combinations and tigecycline are the alternative drugs for immunosuppressed cases[18]. The majority of the patients reported in the medical literature received beta-lactam group antibiotics. Because of severe hypersensitivity to beta-lactam agents, we administered tigecycline to our patient under close monitoring.

Tigecycline, an antibiotic from the glycylcycline class, has a wide antibacterial spectrum with activity against gram-positive and gram-negative aerobic and anaerobic bacteria and good tissue penetration[19]. Although it is a bacteriostatic antibiotic, some in vitro studies revealed its cidal activity against Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria gonorrhoeae[20, 21]. In the literature to date, only two case reports of mediastinitis mentioned its safety and therapeutic success when used together with surgical debridement and drainage. One of them was panresistant Acinetobacter baumannii mediastinitis and the other was multi-drug-resistant Klebsiella pneumoniae mediastinitis[22, 23]. Their characteristic features in comparison to the case presented herein are summarized in Table 1. Despite its bacteriostatic feature, tigecycline has been reported to be used successfully in the treatment of severe infections[24, 25]. It has high penetration into skin and soft tissues[26]. Our patient was treated successfully with tigecycline as he was young, immunocompetent, with no underlying disease and because of the early diagnosis by means of CT and urgent surgical intervention.

Table 1: Comparative characteristic features of the two previously reported cases and the present case of mediastinitis treated with tigecycline

In conclusion, tigecycline has the potential to be an alternative option for treatment of odontogenic infections and descending mediastinitis. It may be used effectively and successfully with concurrent standard surgical intervention in selected patients, especially in those with severe hypersensitivity reaction to betalactam antibiotics.

References

1
Van Schooneveld TC, Rupp ME. Mediastinitis. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone, 2010:1173-82.
2
Chow AW. Life-threatening infections of the head, neck, and upper respiratory tract. In: Hall JB, Schmidt GA, Wood LDH (eds). Principles of Critical Care. 2nd ed. New York: McGraw-Hill, 1998:887.
3
Al-Ebrahim KE. Descending necrotising mediastinitis: a case report and review of the literature. Eur J Cardiothorac Surg 1995;9:161-2.
4
Yetim TD, Okuyucu Ş, Akoğlu SG, Balcı A, Ekşi G. Desendan nekrotizan mediastinit: nadir bir olgu. J Kartal TR 2012;23:45-8.
5
Makeieff M, Gresillon N, Berthet JP, Garrel R, Crampette L, Marty-Ane C, et al. Management of descending necrotizing mediastinitis. Laryngoscope 2004;14:772-5.
6
Singhal P, Kejriwal N, Lin Z, Tsutsui R, Ullal R. Optimal surgical management of descending necrotising mediastinitis: our experience and review of literature. Heart Lung Circ 2008;17:124-8.
7
Li X, Kollveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev 2000;13:547.
8
Holmstrup P, Poulsen AH, Andersen L, Skuldbol T, Fiehn NE. Oral infections and systemic diseases. Dent Clin North Am 2003;47:575.
9
Prasad KC, Prasad SC, Mouli N, Agarwal S. Osteomyelitis in the neck and head. Acta Otolaryngol 2007;127:194.
10
Boscolo-Rizzo P, Marchiori C, Montolli F, Vaglia A, Da Mosto MC. Deep neck infections: a constant challenge. ORL J Otorhinolaryngol Relat Spec 2006;68:259-65.
11
Iwata T, Sekine Y, Shibuya K, Yasufuku K, Iyoda A, Lizasa T, et al. Early open thoracotomy and mediastinopleural irrigation for severe descending necrotizing mediastinitis. Eur J Cardiothorac Surg 2005;28:384-88.
12
Yang SW, Lee MH, Lee YS, Huang SH, Chen TA, Fang TJ. Analysis of life-threatening complications of deep neck abscess and the impact of empiric antibiotics. ORLJ Otorhinolaryngol Relat Spec 2008;70:249-56.
13
Scaglione M, Pinto A, Giovine S, Di Nuzzo L, Giuliano V, Romano L. CT features of descending necrotizing mediastinitis - a pictorial essay. Emerg Radiol 2007;14:77-81.
14
Sandner A, Bergermann J. Update on necrotizing mediastinitis: causes, approaches to management, and outcomes. Curr Infect Dis Rep 2011;13:278-86.
15
Hsu RF, Wu PY, Ho CK. Transcervical drainage for descending necrotizing mediastinitis may be sufficient. Otolaryngol Head Neck Surg 2011;145:742-7.
16
Weaver E, Nguyen X, Brooks MA. Descending necrotising mediastinitis: two case reports and review of the literature. Eur Respir Rev 2010;19:141-9.
17
Cirino LM, Elias FM, Almeida JL. Descending mediastinitis: a review. Sao Paulo Med J 2006;124:285-90.
18
Slover CM, Rodvold KA, Danziger LH. Tigecycline: a novel broad-spectrum antimicrobial. Ann Pharmacother 2007;41:965-72.
19
Chow AW. Complications, diagnosis, and treatment of odontogenic infections. Available: http://www.uptodate. com//
20
Noskin GA. Tigecycline: a new glycylcycline for treatment of serious infections. Clin Infect Dis 2005;41(Suppl 5):S303-S14.
21
Meagher AK, Ambrose PG, Grasela TH, Ellis-Grosse EJ. Pharmacokinetic/pharmacodynamic profile for tigecyclinea new glycylcycline antimicrobial agent. Diagn Microbiol Infect Dis 2005;52:165-71.
22
Tekce AY, Erbay A, Cabadak H, Yagcı S, Karabiber N, Sen S. Pan-resistant Acinetobacter baumannii mediastinitis treated successfully with tigecycline: a case report. Surg Infect (Larchmt) 2011;12:141-3.
23
Evagelopoulou P, Myrianthefs P, Markogiannakis A, Baltopoulos G, Tsakris A. Multidrug-resistant Klebsiella pneumoniae mediastinitis safely and effectively treated with prolonged administration of tigecycline. Clin Infect Dis 2008;46:1932-3.
24
Anthony KB, Fishman NO, Linkin DR, Gasink LB, Edelstein PH, Lautenbach E. Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline. Clin Infect Dis 2008;46:567-70.
25
Swoboda S, Ober M, Hainer C, Lichtenstern C, Seiler C, Wendt C, et al. Tigecycline for the treatment of patients with severe sepsis or septic shock: a drug use evaluation in a surgical intensive care unit. J Antimicrob Chemother 2008;61:729-33.
26
Stein GE, Smith CL, Missavage A, Saunders JR, Nicolau DP, Battjes SM, et al. Tigecycline penetration into skin and soft tissues. Surg Infect 2011;12:465-7.